在基底性乳腺癌中鉴定基因甲基化-miRNA-转录因子输送循环的表观遗传调节网络
Larissa M Okano1, Alexandre L K de Azevedo2, Tamyres M Carvalho2
1Research Institute Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
Cells
|August 27, 2025
概括
这项研究揭示了包括DNA甲基化和microRNA在内的表观遗传变化如何在基础性乳腺癌 (BLBC) 中创建复杂的调节网络. 这些发现突显了前循环 (FFL) 作为BLBC进展的关键驱动因素,提供了潜在的治疗点.
科学领域:
- *表观遗传学和癌症基因组学
- * 分子生物学和生物信息学
- * 监管网络分析
背景情况:
- 由于其分子复杂性和异质性,基底类乳腺癌 (BLBC) 具有重大临床挑战.
- * 表观遗传变化,特别是DNA甲基化,与BLBC病变有关,但需要对调节机制进行更深入的研究.
- 了解这些机制对于开发针对性治疗这种侵袭性癌症亚型至关重要.
研究的目的:
- * 研究BLBC中的表观遗传调节网络,重点关注远端 cis调节区域的DNA甲基化.
- * 分析这些表观遗传变化对基因,转录因子 (TF) 和微RNA (miRNA) 表达的影响.
- * 确定关键的监管动机,如前循环 (FFLs),这些动机控制着BLBC的发展和发展.
主要方法:
- * 利用癌症基因组图谱 (TCGA) 的数据进行综合分析.
- 使用ELMER和DESeq2工具来识别差异化甲基区域和差异化表达的基因,TF和miRNA.
- * 应用了FANMOD算法来发现TF和miRNA介导的输送循环 (FFL) 和复合FFL.
主要成果:
- 在BLBC中发现了110个TF介导的FL,43个miRNA介导的FL和5个复合的FL.
- * 检测出基因甲基化 (18 个超甲基化,32 个低甲基化),TF 表达 (8 个上调,9 个下调) 和miRNA 表达 (21 个上调,7 个下调) 的显著变化.
- * 关键调节剂包括AR,FOXM1和TEAD4等TF,以及miR-429和miR-4434等miRNA,影响Ras和TGF-β信号传递途径.
结论:
- 这项综合性分析阐明了BLBC复杂的表观遗传,强调了FFL的关键作用.
- * FFLs作为中央调节动机,在BLBC病变中整合DNA甲基化,TFs和miRNAs.
- 确定了监管网络和关键参与者为未来的BLBC诊断和治疗策略提供了有希望的目标.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
MicroRNAs
21.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


